Scientists provide proof of concept for potential new class of cancer drugs

Posted by on June 15, 2016 3:13 pm
Categories: health

A small-molecule inhibitor of the Notch pathway has been discovered by scientists, paving the way for a potential new class of personalized cancer medicines. Aberrant activity in the Notch pathway contributes to the initiation and maintenance of cancer stem cells.

Leave a Reply

Your email address will not be published. Required fields are marked *